Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women
FiRST
Prospective Evaluation of Coronary Artery Disease in Women Presenting With Cardiac Ischemia: an Anatomic and Physiologic Study Comparing Fractional Flow Reserve (FFR) and Instantaneous Free-wave Ratio (iFR) on Cardiac Catheterization With Findings of Inducible Ischemia on Non-invasive Stress Imaging
1 other identifier
observational
500
1 country
1
Brief Summary
A real world study to evaluate outcomes in women based on guideline identified fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) cutoffs for ischemia (ischemia defined as FFR ≤ 0.80 and iFR ≤ 0.89).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 19, 2019
CompletedFirst Submitted
Initial submission to the registry
August 12, 2020
CompletedFirst Posted
Study publicly available on registry
October 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2029
ExpectedNovember 5, 2025
November 1, 2025
7 years
August 12, 2020
November 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Repeat revascularization
Repeat revascularizations will be documented throughout the course of the 5 year follow up period
5 years
Non-fatal myocardial infarction
Non-fatal myocardial infarctions will be documented throughout the course of the 5 year follow up period
5 years
Non-fatal stroke
Non-fatal strokes will be documented throughout the course of the 5 year follow up period
5 years
Cardiovascular death
Cardiovascular related death will be documented throughout the course of the 5 year follow up period
5 years
Study Arms (1)
Women Presenting with Cardiac Ischemia
Women presenting with cardiac ischemia as indicated by standard of care non-invasive stress testing with cardiac magnetic resonance (CMR), SPECT myocardial perfusion, and PET myocardial perfusion imaging. This cohort of women must also meet the clinical criteria to undergo coronary angiography. Women may be approached for consent either before or after their coronary angiography procedure.
Interventions
The study does not determine any interventions. Any intervention performed during coronary angiography is considered standard of care.
Eligibility Criteria
Adult female patients (\>18 years of age) presenting with suspected myocardial ischemia or acute coronary syndrome for evaluation of ischemia by non-invasive stress testing and coronary angiography.
You may qualify if:
- Female ≥ 18 years old at signing of informed consent
- Suspected myocardial ischemia or acute coronary syndrome
- Indication for non-invasive perfusion imaging study
- Indication for diagnostic catheterization
- Eligible for PCI
- Signed informed clinical procedural consent by subject or by surrogate
You may not qualify if:
- Inability to receive adenosine or regadenoson (for example, severe reactive airway disease, marked hypotension, or advanced atrioventricular block without pacemaker.
- Severe cardiomyopathy (ejection fraction \<30%)
- Extremely tortuous or calcified coronary arteries precluding FFR/iFR measurements
- Patients with left main coronary artery disease requiring revascularization
- Female of child baring age should have negative pregnancy test
- Subject is pregnant or breast feeding, or planning to become pregnant
- Contraindication to non-invasive stress imaging including severe claustrophobia, renal disease with GFR \<30 where CMR is indication, any metal in the body which is a contraindication to CMR, allergy to gadolinium contrast
- ICD or PPM
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
Study Sites (1)
Yale University School of Medicine - Section of Cardiology
New Haven, Connecticut, 06520, United States
Related Publications (2)
Gitto, M., Saito Y., Schneider, M., Papoutsidakis, N., Ardito, S., McCarthy, M., Cristea, E., Lansky, A., Altin, E. (2020). Journal of the American College of Cardiology. Discrepancy Between Visually Assessed and Quantitative Coronary Angiography Derived Diameter Stenosis in a Cohort of Women with Stable Coronary Artery Disease, 75(11). https://www.onlinejacc.org/content/75/11_Supplement_1/178
BACKGROUNDGitto, M., Saito Y., Schneider, M., Papoutsidakis, N., Ardito, S., McCarthy, M., Cristea, E., Lansky, A., Altin, E. (2020). Journal of the American College of Cardiology. Quantitative Flow Ratio According to Three-Dimensional Quantitative Coronary Angiography Defined Severity of Stenosis in a Cohort of Women with Stable Coronary Artery Disease, 75(11). https://www.onlinejacc.org/content/75/11_Supplement_1/177
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elissa Altin, MD
Yale University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2020
First Posted
October 22, 2020
Study Start
April 19, 2019
Primary Completion
April 10, 2026
Study Completion (Estimated)
April 30, 2029
Last Updated
November 5, 2025
Record last verified: 2025-11